We are live on ! Find out more
CGNT

Cogentix Medical, Inc.
CGNT

Delisted

CGNT was delisted on the 20th of April, 2018.

Back to rankings

37 hedge funds and large institutions have $15.8M invested in Cogentix Medical, Inc. in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

13% more capital invested

Capital invested by funds: $14M → $15.8M (+$1.76M)

9% more funds holding

Funds holding: 34 → 37 (+3)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
8
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$1.54M
2
Millennium Management
Millennium Management
New York
+$373K
3
MHP
Manatuck Hill Partners
Connecticut
+$255K
4
Renaissance Technologies
Renaissance Technologies
New York
+$213K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$196K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$1.6M
2
NCM
Nantahala Capital Management
Connecticut
-$393K
3
PA
Perceptive Advisors
New York
-$180K
4
PCM
Perkins Capital Management
Minnesota
-$118K
5
Deutsche Bank
Deutsche Bank
Germany
-$64K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$6.3M -$393K -192,493 -6%
PCM
2
Perkins Capital Management
Minnesota
$1.85M -$118K -57,641 -6%
BC
3
Broadfin Capital
New York
$1.51M +$1.54M +753,773 New
Renaissance Technologies
4
Renaissance Technologies
New York
$1.11M +$213K +104,400 +23%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.01M -$37.7K -18,436 -4%
EEG
6
E.E. Geduld
$747K +$511 +250 +0.1%
DCM
7
DAFNA Capital Management
California
$710K – – –
Millennium Management
8
Millennium Management
New York
$367K +$373K +182,797 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$365K +$196K +95,810 +111%
BA
10
Bard Associates
Illinois
$327K -$19.4K -9,513 -6%
MHP
11
Manatuck Hill Partners
Connecticut
$251K +$255K +125,000 New
TA
12
Teton Advisors
New York
$231K – – –
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$157K – – –
AIM
14
Acrospire Investment Management
Illinois
$112K +$114K +55,776 New
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
$110K +$86.3K +42,270 New
Northern Trust
16
Northern Trust
Illinois
$109K +$9.67K +4,735 +10%
VKH
17
Virtu KCG Holdings
New York
$63K +$64.3K +31,496 New
Deutsche Bank
18
Deutsche Bank
Germany
$61K -$64K -31,322 -51%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$50K +$50.1K +24,535 New
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$47K – – –
BIT
21
BlackRock Institutional Trust
California
$46K – – –
SIM
22
Spark Investment Management
New York
$44K +$23.1K +11,300 +103%
GC
23
GMT Capital
Georgia
$43K – – –
First Manhattan
24
First Manhattan
New York
$42K -$1.12K -550 -3%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$29K +$1.31K +640 +5%
1
2

CGNT Hedge Fund Activity: Q4 2016 in Review

37 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q4 2016, worth a combined $15.8M — up 13% from $14M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CGNT positions and 5 closed out — a net gain of 3 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Broadfin Capital, opening a new position worth an estimated $1.54M. The largest seller was OrbiMed, exiting entirely with an estimated $1.6M sold.

  • 37 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q4 2016, up from 34 in Q3 2016.
  • Funds reported $15.8M of Cogentix Medical, Inc. stock for Q4 2016, up 13% quarter-over-quarter.
  • 8 funds opened new Cogentix Medical, Inc. positions in Q4 2016 and 5 closed out, a net change of +3 holders.
  • The largest Cogentix Medical, Inc. buyer in Q4 2016 was Broadfin Capital, an estimated $1.54M added.
  • The largest Cogentix Medical, Inc. seller in Q4 2016 was OrbiMed, an estimated $1.6M sold.

Based on aggregated 13F filings for Q4 2016.